Cargando…
BRN2 expression increases anoikis resistance in melanoma
Melanoma tumors are highly heterogeneous, comprising of many cell populations that vary in their potential for growth and invasion. Differential transcription factor expression contributes to these phenotypic traits. BRN2, a member of the POU domain family of transcription factors is thought to play...
Autores principales: | Pierce, Carly J., Simmons, Jacinta L., Broit, Natasa, Karunarathne, Deshapriya, Ng, Mei Fong, Boyle, Glen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338542/ https://www.ncbi.nlm.nih.gov/pubmed/32632141 http://dx.doi.org/10.1038/s41389-020-00247-1 |
Ejemplares similares
-
MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
por: Simmons, Jacinta L., et al.
Publicado: (2017) -
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
por: Neuendorf, Hannah M., et al.
Publicado: (2023) -
Heterogeneity in Melanoma
por: Ng, Mei Fong, et al.
Publicado: (2022) -
Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process
por: Warren, Timothy A., et al.
Publicado: (2016) -
NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF
por: Fane, Mitchell E., et al.
Publicado: (2017)